| Revenue | 31/10/2018 | 31/10/2017 | 31/10/2016 | 31/10/2015 |
| Total revenue | 3,094,286 | 2,801,687 | 2,600,573 | 2,445,669 |
| Cost of revenue | 1,779,596 | 1,555,901 | 1,438,997 | 1,370,106 |
| Gross profit | 1,314,690 | 1,245,786 | 1,161,576 | 1,075,563 |
| Operating expenses |
| Research development | 491,564 | 475,329 | 451,794 | 414,201 |
| Selling general and administrative | 549,193 | 498,773 | 482,559 | 457,238 |
| Non-recurring | - | - | - | - |
| Others | - | - | - | - |
| Total operating expenses | 2,836,090 | 2,576,732 | 2,434,858 | 2,311,056 |
| Operating income or loss | 258,196 | 224,955 | 165,715 | 134,613 |
| Income from continuing operations |
| Total other income/expenses net | -109,415 | -68,829 | -78,997 | -110,849 |
| Earnings before interest and taxes | 258,196 | 224,955 | 165,715 | 134,613 |
| Interest expense | -55,249 | -55,852 | -56,656 | -51,179 |
| Income before tax | 148,781 | 156,126 | 86,718 | 23,764 |
| Income tax expense | 493,471 | -1,105,827 | 14,134 | 12,097 |
| Minority interest | - | - | - | - |
| Net income from continuing ops | -344,690 | 1,261,953 | 72,584 | 11,667 |
| Non-recurring events |
| Discontinued operations | - | - | - | - |
| Extraordinary items | - | - | - | - |
| Effect of accounting changes | - | - | - | - |
| Other items | - | - | - | - |
| Net income |
| Net income | -344,690 | 1,261,953 | 72,584 | 11,667 |
| Preferred stock and other adjustments | - | - | - | - |
| Net income applicable to common shares | -344,690 | 1,261,953 | 72,584 | 11,667 |